Hasil Pencarian - Yule Chen
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 15 hasil dari 15
-
1
Study on Small Samples Active Sonar Target Recognition Based on Deep Learning oleh Yule Chen, Hong Liang, Shuo Pang
Diterbitkan 2022-08-01
Artikel -
2
DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS oleh Min Jiao, Hui Guo, Yule Chen, Lei Li, Linlin Zhang
Diterbitkan 2020-08-01
Artikel -
3
Serum Metabolomic Patterns in Patients With Aldosterone-Producing Adenoma oleh Yule Chen, Yule Chen, Hanjiang Wang, Ke Wang, Ke Wang, Guodong Zhu, Guodong Zhu, Zhishang Yang, Zhishang Yang, Min Wang, Wenbin Song, Wenbin Song
Diterbitkan 2022-04-01
Artikel -
4
-
5
-
6
-
7
De Novo Design of an Androgen Receptor DNA Binding Domain‐Targeted peptide PROTAC for Prostate Cancer Therapy oleh Bohan Ma, Yizeng Fan, Dize Zhang, Yi Wei, Yanlin Jian, Donghua Liu, Zixi Wang, Yang Gao, Jian Ma, Yule Chen, Shan Xu, Lei Li
Diterbitkan 2022-10-01
Artikel -
8
Development of a Double-Stapled Peptide Stabilizing Both α‑Helix and β‑Sheet Structures for Degrading Transcription Factor AR-V7 oleh Bohan Ma, Donghua Liu, Mengjun Zheng, Zhe Wang, Dize Zhang, Yanlin Jian, Jian Ma, Yizeng Fan, Yule Chen, Yang Gao, Jing Liu, Xiang Li, Lei Li
Diterbitkan 2024-01-01
Artikel -
9
Development of a PAK4-targeting PROTAC for renal carcinoma therapy: concurrent inhibition of cancer cell proliferation and enhancement of immune cell responseResearch in context oleh Shan Xu, Bohan Ma, Yanlin Jian, Chen Yao, Zixi Wang, Yizeng Fan, Jian Ma, Yule Chen, Xiaoyu Feng, Jiale An, Jiani Chen, Ke Wang, Hongjun Xie, Yang Gao, Lei Li
Diterbitkan 2024-06-01
Artikel -
10
Discovery of a peptide proteolysis-targeting chimera (PROTAC) drug of p300 for prostate cancer therapyResearch in context oleh Dize Zhang, Bohan Ma, Donghua Liu, Wei Wu, Tianyang Zhou, Yibo Gao, Cunli Yang, Yanlin Jian, Yizeng Fan, Yuchen Qian, Jian Ma, Yang Gao, Yule Chen, Shan Xu, Lei Li
Diterbitkan 2024-07-01
Artikel -
11
Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma oleh Wenbin Song, Dalin He, Yule Chen, Chiuan‐Ren Yeh, Iawen Hsu, Qingbo Huang, Xu Zhang, Luke Sien‐Shih Chang, Li Zuo, Jiasheng Chen, Karen M. Doersch, Chawnshang Chang, Lei Li, Shuyuan Yeh
Diterbitkan 2018-12-01
Artikel -
12
Neuroplastic changes induced by long-term Pingju training: insights from dynamic brain activity and connectivity oleh Fangshi Zhao, Linlin Song, Linlin Song, Yule Chen, Shaoying Wang, Xiaoyi Wang, Ying Zhai, Jinglei Xu, Zhihui Zhang, Minghuan Lei, Wenjie Cai, Qi An, Dan Zhu, Dan Zhu, Fengtan Li, Chunyang Wang, Feng Liu
Diterbitkan 2024-09-01
Artikel -
13
USP7 depletion potentiates HIF2α degradation and inhibits clear cell renal cell carcinoma progression oleh Rongfu Tu, Junpeng Ma, Yule Chen, Ye Kang, Doudou Ren, Zeqiong Cai, Ru Zhang, Yiwen Pan, Yijia Liu, Yanyan Da, Yao Xu, Yahuan Yu, Donghai Wang, Jingchao Wang, Yang Dong, Xinlan Lu, Chengsheng Zhang
Diterbitkan 2024-10-01
Artikel -
14
MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation oleh Jian Ma, Lei Li, Bohan Ma, Tianjie Liu, Zixi Wang, Qi Ye, Yunhua Peng, Bin Wang, Yule Chen, Shan Xu, Ke Wang, Fabin Dang, Xinyang Wang, Zixuan Zeng, Yanlin Jian, Zhihua Ren, Yizeng Fan, Xudong Li, Jing Liu, Yang Gao, Wenyi Wei, Lei Li
Diterbitkan 2024-02-01
Artikel -
15
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer oleh Jingyi Liu, Zhibing Duan, Weijie Guo, Lei Zeng, Yadi Wu, Yule Chen, Fang Tai, Yifan Wang, Yiwei Lin, Qiang Zhang, Yanling He, Jiong Deng, Rachel L. Stewart, Chi Wang, Pengnian Charles Lin, Saghi Ghaffari, B. Mark Evers, Suling Liu, Ming-Ming Zhou, Binhua P. Zhou, Jian Shi
Diterbitkan 2018-12-01
Artikel